GGrantIndex
Sort

64,565 grants matching drug discovery

New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency

$1,905,228
David H Perlmutter · Washington University · P01 · FY2021 · DK

Mentored Career Development Program

$1,904,810
Colin A Depp · University Of California, San Diego · KL2 · FY2024 · TR

Mentored Career Development Program

$1,904,810
Colin A Depp · University Of California, San Diego · KL2 · FY2023 · TR

Mentored Career Development Program

$1,904,810
Colin A Depp · University Of California, San Diego · KL2 · FY2021 · TR

Viral Infection Influence on Transplantation Tolerance

$1,904,294
Dale L Greiner · Univ Of Massachusetts Med Sch Worcester · P01 · FY2014 · AI

Molecular and Cellular Pathogenesis in Alcoholism

$1,902,250
Fulton T Crews · Univ Of North Carolina Chapel Hill · P60 · FY2016 · AA

Named Entity Recognition and Relationship Extraction in Biomedicine

$1,901,416
Zhiyong Lu · National Library Of Medicine · ZIA · FY2019 · LM

COBRE Center for Antimicrobial Resistance and Therapeutic Discovery

$1,900,857
Eleftherios Mylonakis · Miriam Hospital · P20 · FY2020 · GM

Pharmacogenomic Evaluation of Antihypertensive Responses

$1,900,848
Julie A. Johnson · University Of Florida · U01 · FY2013 · GM

Identification of Cell Type-Specific Actions of Antipsychotic Drugs

$1,900,797
Paul Greengard · Rockefeller University · P50 · FY2013 · MH

Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface

$1,900,684
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis

$1,900,619
Alex A Adjei · Mayo Clinic Rochester · UM1 · FY2018 · CA

Drug Combination Signatures for Prediction and Mitigation of Toxicity

$1,899,685
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2015 · HG

Drug Combination Signatures for Prediction and Mitigation of Toxicity

$1,899,685
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2016 · HG

Drug Combination Signatures for Prediction and Mitigation of Toxicity

$1,899,685
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2017 · HG

Drug Combination Signatures for Prediction and Mitigation of Toxicity

$1,899,685
Srinivas Ravi V Iyengar · Icahn School Of Medicine At Mount Sinai · U54 · FY2019 · HG

Genetics and Biology of Pancreatic Duct Adenocarcinoma

$1,899,242
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2010 · CA

MEDICINAL CHEMISTRY FACILITY

$1,898,559
Gregg Pioske · University Of Minnesota · N01 · FY2013 · HD

In Situ Tumor Vaccination with a Nano-oligo Therapeutic to Induce Whole-body Antitumor Immune Response

$1,898,361
Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2021 · CA

Coordinating Center for the NHLBI Catalyze Program

$1,897,613
Diana M Severynse-Stevens · Research Triangle Institute · OT2 · FY2020 · HL

Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease

$1,897,529
Clinton H. Joiner · Emory University · U01 · FY2013 · HL

Therapies for patients with rare tumors and genetic tumor predisposition

$1,897,099
Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2022 · CA

Rare & Mosaic Disorders Molecular Research

$1,896,367
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2021 · HG

Development of MRI Techniques for Applications in Substance Use Disorders

$1,896,197
Yihong Yang · National Institute On Drug Abuse · ZIA · FY2025 · DA

Clinical Research Support for the CCR

$1,895,729
Robert Wiltrout · Division Of Basic Sciences - Nci · ZID · FY2011 · CA